New Delhi/Washington | Special Report | PaperPatrikaContentsWhat Is Trump’s Proposed Tariff Plan?Why Is the Indian Pharmaceutical Industry Concerned?Why Experts Say Americans Could Be the Biggest LosersImportance of Generic Medicines in the United StatesCan Manufacturing Be Shifted to the U.S. Quickly?Potential Impact on Indian Pharmaceutical CompaniesCan India Maintain Its Competitive Advantage?Implications for India–U.S. Trade RelationsIndustry RecommendationsGlobal … Continue reading Trump’s 200% Generic Drug Tariff Threat Could Hurt American Patients, Warns Indian Pharma Industry